A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies

Clinical trial NCT04772989 · COMPLETED

Trial details

NCT number: NCT04772989
Sponsor: Arcus Biosciences, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor Non Small Cell Lung Cancer (NSCLC)Melanoma Cervical Cancer Multiple Myeloma Lymphoma, Non-Hodgkin Diffuse Large B Cell Lymphoma (DLBCL)Gastric Cancer Gastroesophageal Junction Adenocarcinoma Esophageal Cancer

Start date: 2021-03-19
Primary completion: 2025-08-25
Enrollment: 94

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.